Abstract-The mechanism of stimulatory action of thyrotropin-releasing hormone (TRH) on spontaneous motor activity was investigated in rats. TRH produced a significant hyperactivity with intraperitoneal administration of 20 mg/kg or bilateral injection of 10 pg into the nucleus accumbens septi (NAS). Following bilateral injection of 6-hydroxydopamine into the mesolimbic dopamine (DA) pathway, the hyperactivity induced by TRH was not altered, whereas the response to apomorphine given intraperitoneally or DA injected into the NAS was clearly enhanced. The TRH-induced hyperactivity was remarkably suppressed by a-methyltyrosine and in contrast, augmented by pargyline. Systemic injection of aminooxyacetic acid in a dose producing behavioral depression reduced markedly the TRH-induced hyperactivity. Bilateral injection of ethanolamine 0-sulphate (100 pg) into the NAS produced no behavioral depression per se, but remarkably attenuated the hyperactivity response to TRH or DA (20 pg) given intraperitoneally or into the NAS. Both TRH (10-1 and 10-' M) and methamphetamine (10-6-10-4 M) increased the spontaneous release of 14C-DA from rat NAS slices . These findings suggest that TRH induces hyperactivity by enhancing DA release from nerve terminals in the NAS without a direct stimulation of the post-synaptic DA receptors. TRH and GABA, independently or via interaction between them, may play a reciprocal regulatory role in the activity of the mesolimbic DA system. Thyrotropin-releasing hormone (TRH) has central effects which may be independent of its releasing action of thyrotropin and prolactin from the anterior pituitary. These findings have been reported by different workers who found that the peptide itself produced behavioral excitation and modified behavioral effects of central depressants in intact, hypo physectomized and thyroidectomized animals (1-3). TRH is widely distributed throughout the brain and two-thirds are located outside the hypothalamus (4). Radioimmunological evidence of Hokfelt et al. (5) indicating that TRH is contained in nerve terminals of several brain regions, in particular the nucleus accumbens (NAS), is of great interest, since this nucleus is one of the most significant sites of mesolimbic dopamine (DA) system (6) and is postulated to be important for spontaneous motor activity and antipsychotic effect of neuroleptics (7-9). These reports suggest that TRH may have some neuroregulatory role in spontaneous motor activity or emotional activity in addition to the role of releasing hormone. The evidence in our previous study indicated that a significant spontaneous motor
activity stimulation induced by i.p. or intra-NAS injection of TRH in rats was blocked by haloperidol or pimozide, suggesting an important role of the mesolimbic DA system in mediating the TRH effect (10) . There is a view that r-aminobutyric acid (GABA) may act as an inhibitory neurotransmitter on the mesolimbic DA system (11, 12) . In support of this view, a high level of GABA has been demonstrated in the NAS (13) . Furthermore, pharmacological studies showed that GABAergic drugs markedly suppress the locomotor stimulatory action of DA or ergometrine injected into the NAS (14, 15) .
With regard to the spontaneous motor stimulatory action of TRH in rats, the present study was done to determine whether TRH acts pre or postsynaptically on DA neurons in the NAS, and whether or not the effect is modified by GABAergic drugs.
MATERIALS AND METHODS
Animals: Male Sprague-Dawley (JCL:SD) rats weighing 200-300 g, 7-8 weeks old at the start of behavioral testing, were used. Some of these rats were subjected to surgery 7 days earlier or intracerebral injection of 6-hydroxydopamine (6-OHDA) 14 days earlier.
The NAS slices were prepared from 8-12 weeks old rats weighing 300-500 g. Most of these rats were utilized only once for experiment but some animals were utilized twice at intervals (17) . Drugs were dissolved in physiological saline, except 6-OHDA which was dissolved immediately before use in an ice-cold physiological saline containing 0.1 ascorbic acid. The doses are expressed in terms of the salts used.
Injection of drugs into the NAS was made bilaterally by means of a microsyringe with a needle of 0.4 mm outer and 0.2 mm inner diameters which extended into the brain tissue 1.5 mm below the tip of the guide cannulae. One jl was injected into each side. The volume for i.p. administration was 0.2 ml/100 g b.wt. Control rats were given an equal volume of physiological saline i.p. or into the NAS.
Lesions of the mesolimbic DA pathway by 6-OHDA: For selective lesions of the mesolimbic DA system by the local, intracerebral injection of 6-OHDA, the rats were anesthetized with chloral hydrate (300 mg/kg i.p.) and fixed on a stereotaxic instrument.
The injection needles with 0.4 min outer and 0.2 mm inner diameters were positioned bilater ally in the mesolimbic DA pathway (6) located at the coordinates: A 7.5, L 1.4, H -1.2 (Konig and Klippel) (18). 6-OHDA (8 pg of a 4 leg/,ul solution) was delivered from a microsyringe to the tip of the needle on each side at a rate of I ftl/min. The injection volume and rate were selected to minimize nonspecific damage at the site of injection.
Implantation of guide cannulae in the NAS: Normal rats and 6-OHDA lesioned rats were anesthetized with pentobarbital (40 mg/kg i.p.) and fixed on a stereotaxic instrument.
The stainless steel guide cannulae with 0.8 mm outer and 0.5 mm inner diameters were implanted bilaterally in the NAS located at the coordinates of the De Groot atlas (19):
A 9.4, L 1.6, H 1.0. The cannulae were fixed onto the skull with acrylic dental cement.
Stainless steel stylets with 0.4 mm diameter, extending 1 mm below the tips of the guide cannulae, were retained to prevent occulsion of the lumen by blood and tissue. The rats were used for intracerebral injection of drugs after 7 postoperative days.
Injection of ethanolamine O-sulphate (EOS) into the NAS: According to the procedure described in the intracerebral injection of 6-OHDA, a specific active-site-directed GABA transaminase inhibitor EOS (100 ,rig in 1 pl saline) was injected bilaterally into the NAS at the coordinates of the De Groot atlas (19): A 9.4, L 1.6, H -0.5. The dose of EOS used was selected on the basis of the report by Pycock and Horton (14) , in which they described that GABA levels in the rat NAS were remarkably increased on day 1 after EOS injection into the bilateral NAS and that these levels returned to normal by day 7.
Sham-operated control rats for 6-OHDA lesion and EOS injection were anesthetized with chloral hydrate, a hole was drilled on the skull but needles were not inserted.
Measurement of spontaneous motor activity: Each rat was placed in a perspex cage Histology: At the end of the experi ments the rats with implanted intra-NAS cannulae were perfused with 30 ml of saline followed by 50 ml of 10% formalin through the left cardiac ventricle under pentobarbital anesthesia. The brains were removed and kept in 10% formalin for at least 7 days and then sectioned to verify the site of injection. All the in jection sites were found to be located in the NAS (Fig. 1) . 
RESULTS
TRH-induced spontaneous motor activity stimulation in sham-operated rats and in rats with 6-OHDA lesions of the mesolimbic DA pathway
In normal and sham-operated rats, TRH (20 mg/kg i.p.) induced a significant spontaneous motor activity stimulation accompanied by increases in locomotion, rearing, sniffing, grooming and preening, and also produced head-shaking, mild tail-elevation and self-biting of forepaws. A similar spontaneous motor activity stimulation and other behavior except tail-elevation and self-biting were also caused by bilateral injection of TRH (10 tig) into the NAS (Table 1) . These effects attained to a maximum within 10 min following injection, then gradually diminished (Figs. 4 and 5 ).
The spontaneous motor stimulatory actions of TRH, apomorphine and methamphe tamine given i.p. were compared between sham-operated rats and lesioned rats on days 2, 7, 14 and 28 following bilateral injection of 6-OHDA into the mesolimbic DA pathway (Fig. 2) . The effects of TRH and DA injected into the NAS in both types of rats were also compared on day 14 following 6-OHDA injection (Fig. 3) . The intensities of spontaneous motor activity and other behavior in response to TRH given i.p. or into the NAS in 6-OHDA lesioned rats were not significantly different from that in sham-operated rats (Table 1) . On the other hand, a DA receptor agonist, apomorphine (1 mg/kg i.p.) produced significantly more intensive spontaneous motor activity stimulation on all test days in the lesioned rats than in sham-operated controls. An enhanced spontaneous motor activity stimulation in the lesioned rats was similarly observed after bilateral injection of DA (20 ug) into the NAS. Although the spontaneous motor stimulatory action of methamphetamine (2 mg/kg i.p.) was significantly potentiated on day 7 following 6-OHDA injection, there were no significant changes observed on other days.
Brain DA and NA contents on day 14 following bilateral 6-OHDA injection into the mesolimbic pathway are presented in Table 2 . Both DA and NA contents of the NAS were markedly reduced: DA levels fell to 30% and NA levels to 12% of sham-operated controls, respectively. This treatment also reduced the striatal DA levels (to 49 % of control) and NA levels (to 34 %), and the cortical NA levels (to 18 %).
Effect of pretreatment with pargyline or a-methyltyrosine (a-MT) on TRH-induced spontaneous motor activity stimulation
The effects of a monoamine oxidase inhibitor, pargyline and a tyrosine hydroxylase inhibitor, a-MT on the spontaneous motor stimulatory action of TRH were studied. Pre treatment with pargyline (100 mg/kg i.p.) which produced no spontaneous motor activity stimulation per se, significantly enhanced the spontaneous motor stimulatory action of TRH, 10 and 20 mg/kg i.p. (Fig. 4) ; particularly locomotion, rearing and sniffing were markedly enhanced (Table 1) . On the contrary, pretreatment with a-MT (250 mg/kg i.p.) significantly reduced the effect of TRH given i.p. or into the NAS (Fig. 5) . Locomotion, rearing and sniffing induced by TRH were abolished by a-MT, but head-shaking, tail-elevation and self biting still remained (Table 1) . manner by pretreatment with aminooxyacetic acid (AOAA), 12.5, 25 and 50 mg/kg i.p. (Fig.   6 ). The highest dose (50 mg/kg i.p.) of AOAA, however, induced a considerable depression accompanied by a marked muscle relaxation per se. EOS (100 , g) injected bilaterally into the NAS did not produce any sign of behavioral depression per se, but significantly suppressed the spontaneous motor stimulatory action of TRH (20 mg/kg i.p.) or DA (20 pg) injected into the same nucleus on day 1. Of all the behavior observed following the administration of TRH (20 mg/kg i.p.), locomotion, rearing and sniffing were markedly reduced by EOS injection (Table 1) . On day 7 following EOS injection, however, the spontaneous motor stimulatory response to TRH and DA was indistinguishable from that in sham-operated controls (Fig. 7) .
Effect of TRH on the release of 14C-DA from rat NAS slices Effects of TRH and methamphetamine on the release of 14C-DA from rat NAS slices by superfusion are shown in Table 3 . TRH (10-1 and 10-4 M) significantly accelerated the spontaneous 14C-DA release. Methamphetamine (10-6-10-4 M) also markedly enhanced the release of 14C-DA from the slices. We previously reported that the DA system in the NAS is an important site in mediating the spontaneous motor stimulatory action of TRH in rats, based on the observation that the effect of TRH injected systemically or into the NAS was abolished by injection of a DA receptor antagonist, haloperidol or pimozide systemically or into the NAS (10) . In that report, however, there was no description as to whether TRH acted on presynaptic or post synaptic sites of the DA neurons. The focal, intracerebral injection of 6-OHDA would appear to produce a selective lesion in the DA system, and this technique has been employed by some investigators to analyze the role of various DA-containing areas in behavioral effects of central stimulants, for instance, the spontaneous motor stimulatory action of DA receptor agonist is found to be markedly enhanced in rats with 6-OHDA injected either into the mesolimbic DA pathway or into the NAS containing DA nerve terminals (9, 22, 23) . This phenomenon is thought to be due to supersensitivity by 6-OHDA. Coinciding with the above observation, a markedly enhanced spontaneous motor activity in response to the DA receptor agonist, apomorphine injected systemically or DA injected into the NAS in the 6-OHDA lesioned rats was observed in the present investigation. In this condition, the spontaneous motor stimulatory action of TRH injected either systemically or into the NAS was unaltered. This finding suggests that TRH lacks a direct stimulatory action on the DA receptors in the NAS.
If injection of 6-OHDA directly into nerve terminals or into mesolimbic inputs induces a complete denervation of the nerve terminals, it should abolish the effect of a drug which acts via presynaptic DA mechanisms. Kelly et al. (9) have reported that bilateral injection of 6-OHDA into the NAS markedly attenuated the locomotor stimulation induced by amphetamine. However, in their subsequent report (22) , amphetamine-induced locomotor stimulation was not reduced in 6-OHDA lesioned rats but was significantly attenuated in pargyline and/or desipramine-pretreated 6-OHDA lesioned rats. Costall et al. (23) have reported that bilateral injection of 6-OHDA into the NAS or into the DA pathway fails to modify the intensity of amphetamine hyperactivity although the duration of the effect was reduced. In the present investigation, the hyperactivity response to TRH or methampheta mine, which is probably similar to amphetamine in mode of action, was not attenuated by 6-OHDA injection into the mesolimbic DA pathway. These effects may be due to the release of DA from incompletely denervated nerve terminals, which in turn activated the receptors previously rendered supersensitive. This is also supported by the biochemical data that about 30 % of DA in the NAS remained even after 6-OHDA lesion. Accordingly, the results obtained in the 6-OHDA lesioned rats do not rule out the possibility that TRH may be acting via presynaptic DA mechanisms.
A tyrosine hydroxylase inhibitor, a-MT has been known to deplete both NA and DA in the brain and to abolish the amphetamine response. The spontaneous motor stimulatory action of TRH was markedly attenuated by a-MT and by contrast, enhanced by a monoamine oxidase inhibitor, pargyline. These findings suggest that TRH may activate presynaptically DA neurons in the NAS to release DA from the nerve terminals and produce the spontaneous motor activity stimulation. Recent evidence suggests that the activity of the nigrostriatal DA system is controlled in the nigral cell bodies by long descending GABAergic fibers from the striatum (26, 27) and locally in the striatum by short GABAergic fibers (28) . The mesolimbic DA system also seems to be under GABAergic control in both the A10 cell bodies and the mesolimbic structures (11, 12, 29) . In fact, the NAS contains the highest concentration of GABA in the brain (13) . These views allow for speculation that GABAergic and TRH neurons both regulate locally the excitability of the DA neurons in the NAS. Therefore, we first studied the effect of a GABA-transaminase inhibitor, AOAA on TRH-induced spontaneous motor stimulation. In agreement with a previous report (30) , AOAA given i.p. significantly suppressed the hyperactivity response to TRH in rats. However, AOAA at the doses used induced behavioral depression accompanied by ataxia per se, allowing a partial involvement of a nonspecific factor in reducing the TRH effect. In an attempt to increase the local GABA levels, a specific active-site-directed GABA transaminase inhibitor, EOS (31) was injected bilaterally into the NAS. This treatment did not induce any behavioral depression per se, but remarkably suppressed the hyperactivity response to TRH given i.p., in parallel with the time-course of elevated GABA levels in the NAS, as described by Pycock and Horton (14) . A similar suppression by EOS on the hyperactivity response to DA injected into the NAS was also observed in our experiment. These findings suggest that both TRH and GABA independently or via an interaction may play a role as reciprocal neuroregulatory transmitters in the NAS of the mesolimbic DA system, this system being related to the spontaneous motor activity in animals and probably to emotional activity in humans (7) (8) (9) 32) . The activating effect of TRH on the mesolimbic DA system may also explain, at least partially, the clinical findings that administration of TRH improves "instinctive" behavior or mood in depressive patients and facial expression, rapport and psychomotor activity in
